Joshua Boger at #JPM24 (Brian Benton Photography)
January 12, 2024 09:06 AM ESTUpdated 10:00 AM
People
Startups

Ver­tex founder Joshua Boger on sur­viv­ing down­turns, 'painful' part­ner­ships, and the im­por­tance of cul­ture: #JPM24

Andrew Dunn

Senior Biopharma Correspondent

While the JP Mor­gan Health­care Con­fer­ence was full of voic­es of mea­sured op­ti­mism, root­ing for the mar­ket to bounce back in 2024, one long­time biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times